Not affiliated with the Pennsylvania General Assembly · an independent reference by Fifty Domes

PlansSign in

Bills › 2025–2026 Regular Session › House of Representatives bill

HB 27492025–2026
bill

2025–2026 Regular Session · House of Representatives bill

HB 2749

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

In committee Last action August 25, 2026: Referred to Health

Official bill page and text: palegis.us

Sponsors 5

Prime sponsor
Liz Hanbidge
Cosponsors (4)
Ben Waxman, Benjamin Sanchez, Dan Williams, Lindsay Powell

Status

In committee as of August 25, 2026. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

DateChamberAction
August 25, 2026HouseReferred to Health

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.